VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by garygpon Aug 21, 2015 1:08pm

77 Views

Post# 24040471

RE:RE:RE:RE:RE:ABSOLUTELY NOTHING

Sonny; You are right in that you are not the source of any of my misery as it relates to VPT. Given your response to my post, it's also abundantly clear you are not a source of any form of critical or intelligent dialogue, have no understanding of investment or business practices, and are more than happy having the CEO of a publicly traded company lie to you and spend your money in a frivolous manner. It's also clear your position in the company is in the 100 share range. Back under your rock buddy. Gary.

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023